Related Experiment Video
Updated: Aug 18, 2026

Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents
Published on: July 3, 2013
Effect of verapamil on retrograde ventriculo-atrial conduction in children
Insights
Verapamil, a slow channel blocker, was studied in children undergoing cardiac catheterization. It was found to abolish retrograde atrioventricular (V-A) conduction, potentially explaining its antiarrhythmic effects on reentrant arrhythmias.
Area of Science:
- Cardiology
- Electrophysiology
- Pharmacology
Background:
- Retrograde atrioventricular (V-A) conduction plays a role in reentrant arrhythmias.
- Verapamil is a potent antiarrhythmic drug and a slow channel blocker.
- Understanding verapamil's effect on V-A conduction is crucial for managing certain cardiac arrhythmias.
Purpose of the Study:
- To investigate the effects of verapamil on retrograde V-A conduction in pediatric patients.
- To determine if verapamil can abolish or prolong retrograde V-A conduction.
- To correlate the observed effects with verapamil's antiarrhythmic properties.
Main Methods:
- A study involving 12 children undergoing diagnostic cardiac catheterization.
- Administration of a single intravenous dose of verapamil (0.15 mg/Kg).
- Electrophysiological recordings including surface EKG, intra-atrial, and His bundle electrograms before and after verapamil administration.
- Right ventricular pacing with extra stimulus technique was employed.
Main Results:
- Verapamil prolonged the AH interval in 9 out of 12 children.
- Retrograde V-A conduction was abolished in 5/12 children and prolonged in 1/12.
- In all cases where retrograde V-A conduction was present, its duration exceeded antegrade conduction time.
Conclusions:
- Verapamil effectively abolishes retrograde V-A conduction when present.
- This abolition of retrograde V-A conduction may contribute to verapamil's antiarrhythmic efficacy in reentrant arrhythmias.
- Verapamil demonstrates significant impact on cardiac electrophysiology, particularly concerning V-A pathways.
Abstract:
The effects of verapamil, a slow channel blocker and a potent antiarrhythmic drug, on retrograde V-A conduction were investigated following diagnostic cardiac catheterization in 12 children premedicated with lytic cocktail. Surface EKG, intra-atrial and His bundle electrograms, as well as right ventricular pacing with use of extra stimulus technique were obtained before and after a single intravenous dose of verapamil (0.15 mg/Kg, max 5 mg). Verapamil prolonged the AH interval in 9/12 and abolished or prolonged the retrograde V-A conduction whenever present (abolition in 5/12 and prolongation in 1/12). The duration of retrograde V-A conduction exceeded the antegrade conduction time in all. It is concluded that verapamil abolishes retrograde V-A conduction whenever present and this phenomenon may further explain the antiarrhythmic effects of the drug on retrograde conduction dependent (reentrant) arrhythmias.
More Related Videos
Related Concept Videos
Mechanism of Cardiac Arrhythmias
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Cardiac Action Potential
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
Dysrhythmias IV: Characteristics of Bradyarrhythmias
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

